Now Enrolling for 2027. Start Here.

Enrolling Now!

Here’s Your Year-End Quality Playbook

Published September 2nd, 2026

Your practice is in the final stretch of the measurement year. Every gap still open on December 31 represents a patient who did not receive care they were due, and closing it requires outreach, scheduling, documentation and follow-through from your team.

This page consolidates the published resources for the measures receiving the most attention across the network between now and year-end — what each measure counts, which markets it applies in, and every member resource and related article we have published for them. Bookmark this page; additional materials will be added through December.

Equality Health works alongside your practice to engage members and drive year-end gap closure. For additional resources and support, contact your Practice Performance Advisor or PAM.


Well-Child Visits

W15 · W30 · WCV — Medicaid · the first 15 months, 15 to 30 months, and ages 3 through 21, counted inside the measurement year ending December 31

Well-child visits are where developmental delays get caught early, immunizations stay on schedule, and families build a relationship with their care team before something goes wrong. For many of the children in our network it’s the only preventive touchpoint they’ll have all year.

Remember, the highest-yield move on this measure is usually a visit already on your schedule: an acute or walk-in visit converted with modifier 25.

For patients and families

  • Well Child Visit Member Guide (PDF, EN/ES) — what a well-child visit covers, the screenings that happen at it, and how to be a partner in your child’s care

Read More


Childhood Immunizations

CIS · Medicaid · children who turn two during the measurement year

Ten vaccine families must land before a child’s second birthday to close an open gap, and that deadline does not move. A dose given after it still protects the child, but it no longer counts toward the measure — and neither does a chart note saying the child is up to date with all immunizations.

Like well-child visits, a practice can easily convert a sick visit into a CIS or IMA opportunity – use CareEmpower® to evaluate a patient’s open gaps at the time of scheduling.

For patients and families

Read More


Well-Woman Care

CCS · BCS · CHL · PPC1 & PPC2 — CCS applies in every market; BCS in Arizona, Tennessee and Texas; PPC2 in Arizona, Texas, Louisiana and Virginia

Proactive screening has reduced cervical cancer mortality by more than 50% over the last 30 years, and it works because it finds changes before they become cancer. Remember that CCS counts a specimen collected and a result returned. A referral to OB/GYN does not meet it, and a biopsy is a diagnostic test rather than a screening one.

These measures sit together because one well-woman visit can close several of them at once:

  • Cervical screening for members 21 to 64
  • A mammogram order for members 40 to 74
  • A chlamydia screen for members 16 to 24
  • The postpartum visit that falls 7 to 84 days after delivery

Two things are worth knowing when you review the CareEmpower worklist:

  • In-office HPV self-collection is supported for members 30 and over, and cervical screening is a payable activity in every market.
  • Chlamydia screening billed under prenatal or postpartum billing may not be captured on the claim — make sure the screening code appears separately.

For patients and families

Read More


Diabetes and Glycemic Status

GSD8 & GSD9

Glycemic status is not one measure, and it does not run the same way in every market:

  • GSD8 counts members whose most recent A1c or GMI is under 8.0%.
  • GSD9 counts members above 9.0% and is scored in reverse, so a lower rate is the better result.

A practice in Arizona is measured on both; a practice in Louisiana is measured only on the second. Check which target your market is scored against before you build the worklist, because the two point in opposite directions.

Understanding your market’s GSD nuances is an important step in setting up your year-end gap playbook. Your PPA can help you create a glycemic worklist and walk the market-specific target with you.

For patients and families

For your team

  • Kidney Health Evaluation (KED) Quality Guide (PDF, EN) — the two tests that close KED together, an eGFR blood test and a quantitative uACR urine test, with the CPT pair 82403 + 82570 and eight workflow best practices

Read More


Blood Pressure Control

CBP — every market · ages 18 to 85 with a hypertension diagnosis · a most recent reading under 140/90

CBP is the most uniform measure in this push — one threshold, one age band, every market. It also has a shape that makes December the month it is most winnable: the measure looks at the most recent documented reading in the measurement year, so a controlled reading taken and recorded before December 31st replaces an earlier uncontrolled one.

A member who looked open in October can close in December on a single well-documented visit. The tracking best practice is CPT II coding on every encounter where a pressure is taken: 3074F–3080F for systolic and diastolic values.

For patients and families

Read More


Need training on any of these? Your Practice Performance Advisor can walk your team through workflows, gap lists and documentation — and a lot of what’s on this page started as a request from a practice. If your team needs something that isn’t here yet, tell your PPA.

Related Posts

Equality Health network providers benefit from a financial model that incentivizes better...

Equality Health’s Care Model leverages data-driven technology and tools like CareEmpower to...

Equality Health’s Care Model is Dedicated to Better patient outcomes through value-based...